Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

120.83
-1.3291-1.09%
Volume:13.02K
Turnover:1.57M
Market Cap:102.71M
PE:- -
High:123.15
Open:123.00
Low:118.50
Close:122.16
52wk High:126.40
52wk Low:54.56
Shares:850.00K
Float Shares:850.00K
Volume Ratio:0.69
T/O Rate:1.53%
Dividend:0.32
Dividend Rate:0.26%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

TradingKey
·
Aug 10

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS
·
Aug 10

Erasca Appoints Charles Fuchs as President of R&D

Reuters
·
Aug 10

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Reuters
·
Aug 10

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS
·
Aug 10

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Reuters
·
Aug 08

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

TIPRANKS
·
Aug 08

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Dow Jones
·
Aug 08

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Dow Jones
·
Aug 08

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 07

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Dow Jones
·
Aug 07

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

TIPRANKS
·
Aug 07

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Dow Jones
·
Aug 06

Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million

Reuters
·
Aug 06

Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook

Reuters
·
Aug 06

Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment

Reuters
·
Aug 06

Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000

Reuters
·
Aug 06